[SRNE] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
08-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -144.42%
YoY- -310.19%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 6,477 3,913 4,665 902 1,173 775 142 88.96%
PBT -70,654 -74,081 -16,137 -46,113 -10,975 -8,454 -4,737 56.86%
Tax -383 -1,377 -1,398 -1,164 -17 5 2 -
NP -56,762 -73,864 -14,187 -44,949 -10,958 -8,454 -4,737 51.24%
Tax Rate - - - - - - - -
Total Cost 63,239 77,777 18,852 45,851 12,131 9,229 4,878 53.24%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -876.36 -1,887.66 -304.12 -4,983.26 -934.19 -1,090.84 -3,345.11 -20.00%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -0.46 -0.73 -0.20 -0.97 -0.30 -0.33 -0.35 4.65%
EPS Diluted -0.43 -0.73 -0.20 -0.97 -0.30 -0.33 -0.35 3.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.